Certified in Healthcare Compliance (CHC) Practice Test 2025 - Free CHC Practice Questions and Study Resources

The confidentiality of substance use disorder patient records is specifically governed by 42 CFR Part 2. This regulation is designed to protect the privacy of individuals seeking treatment for substance use disorders by ensuring that their records cannot be disclosed without their consent. It provides strict guidelines on how information regarding substance use treatment must be handled, distinguishing it from other health information that may be regulated under general privacy laws like HIPAA.

One of the key features of 42 CFR Part 2 is that it restricts the disclosure of information about individuals who receive substance use disorder treatment, regardless of the setting where the treatment occurs. This protection is crucial for encouraging individuals to seek the help they need without fear of judgment or repercussions from their health records being shared.

While HIPAA provides a framework for the protection of health information in general (as mentioned in other options), 42 CFR Part 2 offers more specific rules tailored to substance use disorder records, underlining its importance in the context of confidentiality for this sensitive population.